References

• Andaç A, Yaşayan G, Alarçin E, Okuyan B, Şahbaz S (2015). Eczane Mesul Müdürlerinin Magistral İlaç Hazırlama ile ilgili Bilgi ve Tutumlarının Değerlendirilmesi. J Pharm Res 19: 283-289. google scholar
• Baytop T (1997). Laboratuvardan Fabrikaya: Türkiye’de İlaç Sanayii (1833-1954). Görsel Sanatlar Matbaacılık, İstanbul. google scholar
• Brion F, Nunn A, Rieutord A (2003). Extemporaneous (magistral) preparation of oral medicines for children in European hospitals. Acta Paediatrica 92: 486-490. google scholar
• Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, Anker J (2000). Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ 320: 79-82. google scholar
• Emmerton L, Marriott J, Bessell T, Nissen L, Dean L (2005). Pharmacists and Prescribing Rights: Review of International Developments. J Pharm Pharmaceut Sci 8: 217-225. google scholar
• Ergün H, Berk B, Uludağ M, Diler İ, Demir ED, Gümüşel B (2010). Türkiye’de eczanelerde hazırlanan (magistral) nitrogliserin merhemlerinin içerik ve sunum özellikleri yönünden değerlendirilmesi. Marmara Eczacılık Dergisi 14: 130-135. google scholar
• Garcia MC, Manzo RH, Jimenez-Kairuz AF (2015). Extemporaneous benznidazole oral suspension prepared from commercially available tablets for treatment of Chagas disease in paediatric patients. Trop Med Int Health 20: 864-870. google scholar
• Geçgil Ş (1991). Farmasötik Teknolojiye Başlangıç. Cihan Matbaacılık, İstanbul. google scholar
• Gubara OA, Gubara TOA, Ayoub MO, Shayoub MEA, Hassan AME, Abd Alla Ah MEA, Ali MEA, Eldim Mahmmoud AN (2016). Extemporaneous Compounding: Attitudes of Community Pharmacists at Khartoum City. World J Pharm Res 5: 119-140. google scholar
• Gubara OA, Shayoub MELA, Haj Elamin AE, Ayoub MO, Tumsah MAR, Masaad AMA, Shyoub AM (2018). Attitudes and Opinion of Hospital Pharmacists Towards Extemporaneous Compounding and Related Issues in Khartoum City: Part II. World J Pharm Res 7: 1-29. google scholar
• Ilgın Ruhi H (2010). Meme Kanserinde Farmakogenetik. Turkiye Klinikleri J Med Sci 30: 16-21. google scholar
• Kairuz T, Chhim S, Hasan F, Kumar K, Lal A, Patel R, Garg S (2007a). Extemporaneous compounding in a sample of New Zealand hospitals: a retrospective survey. N Z Med J 120: 1-9. google scholar
• Kairuz T, Gargiulo D, Bunt C, Garg S (2007b). Quality, Safety and Efficacy in the ‘Off-Label’ Use of Medicines. Curr Drug Saf 2: 89-95. google scholar
• Kristina S, Wiedyaningsih C, Widyakusuma N, Aditama H (2017). Extemporaneous compounding practice by pharmacists: a systematic review. Int J Pharm Pharm Sci 9: 42-46. google scholar
• Leal AS, de BC Menezes MA, Dalmázio I, Sepe FP, Gomes CBT, Santana AS, Cunha LH, Jaćimović R (2012). Quality Control of Formulated Medicines. In Latest Research into Quality Control. InTech: 227-242. google scholar
• Martin K, McPherson T, Fontane P, Berry T, Chereson R, Bilger R (2009). Independent Community Pharmacists’ Perspectives on Compounding in Contemporary Pharmacy Education. Am J Pharm Educ 73: 1-8. google scholar
• Minghettiu P, Giudici E, Montanari L (2000). A Proposal to Improve the Supply of Orphan Drugs. Pharmacol Res 42: 33-37. google scholar
• Neubert A, Wong I, Bonifazi A, Catapano M, Felisi M, Baiardi P, Ceci A (2008). Defining off-label and unlicensed use of medicines for children:Results of a Delphi survey. Pharmacol Res 58: 316-322. google scholar
• Olguín H, Pérez C, Mendiola B, Garduño L, Ramírez E, Pérez J (2009). Comparative Bioavailability of Propafenone after Administration of a Magistral Suspension vs. Commercial Tablets in Healthy Volunteers. Arzneimittelforschung 59: 117-120. google scholar
• Özbek H, Kırmızı N (2016). Magistral ilaçlar: Olgu sunumu. J For Med 30: 256-258. google scholar
• Pereira AC, Miranda ES, Castilho SR, Futuro DO, Teixeira LA, Paula GR (2016). Magistral drugs in hospitalized newborns and children. Revista Paulista de Pediatria 34: 403-407. google scholar
• Pérez R, García BS, Fernández-Llamazares CM, Artigao FB, Julian AN, Peña MJ (2016). The challenge of administering anti-tuberculosis treatment in infants and pre-school children, pTBred Magistral Project. Anales de Pediatría (English Edition) 85: 4-12. google scholar
• Schellekens H, Aldosari M, Talsma H, Mastrobattista E (2017). Making individualized drugs a reality. Nat Biotechnol 35: 507-513. google scholar
• Sellers S, Utian W (2014). Pharmacy Compounding Primer for Physicians Prescriber Beware. Climacteric 17: 19-21. google scholar
• Sklenár Z, Scigel V, Horáčková K, Slanar O (2013). Compounded preparations with nystatin for oral and oromucosal administration. Acta Pol Pharm 70: 759-762. google scholar
• Staubach P, Metz M (2013). Magistral formulations and pruritus therapy – What is established, what is confirmed, what is new? J Dtsch Dermatol Ges 11: 1049-1055. google scholar
• Staubach P, Weisshaar E (2016). Magistralrezepturen zur topischen Therapie des Pruritus. Hautarzt 67: 635-639. google scholar
• Tăerel AE, Soroceanu V, Rais C, Stancu E (2014). Study Of Quality Standards Application In Bucharest Community Pharmacies. Farmacia 62: 1082-1088. google scholar
• TEB-Türkiye Eczacılar Birliği, 22. Bölge Malatya Eczacılar odası. www.malatyaeczaciodasi.org.tr (accessed July 04, 2018). google scholar
• Zaid AN, Al-Ramahi R, Shahed Q, Saleh B, Elaraj J (2012). Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine. Int J Pharm Pract 20: 9-14. google scholar

Citations